MARCHI, ENRICA
MARCHI, ENRICA
Global outcomes and prognosis for relapsed/refractory mature T-cell and NK-cell lymphomas: results from the PETAL consortium
2025 Han, Jessy Xinyi; Koh, Min Jung; Boussi, Leora; Sorial, Mark; Mccabe, Sean M.; Peng, Luke; Singh, Shambhavi; Eche-Ugwu, Ijeoma Julie; Gabler, Judith; Fernandez Turizo, Maria J.; Macvicar, Caroline T.; Garg, Aditya; Disciullo, Alexander; Chopra, Kusha; Lenart, Alexandra; Nwodo, Emmanuel; Barnes, Jeffrey; Koh, Min Ji; Miranda, Eliana; Chiattone, Carlos; Stuver, Robert; Horwitz, Steven M.; Merrill, Mwanasha; Jacobsen, Eric; Manni, Martina; Civallero, Monica; Skrypets, Tetiana; Lymboussaki, Athina; Federico, Massimo; Kim, Yuri; Kim, Jin Seok; Cho, Jae Yong; Eipe, Thomas; Shet, Tanuja; Sridhar, Epari; Shetty, Alok; Saha, Saswata; Jain, Hasmukh; Sengar, Manju; Van Der Weyden, Carrie; Prince, Henry Miles; Hamouche, Ramzi; Murdashvili, Tinatin; Foss, Francine; Gentilini, Marianna; Casadei, Beatrice; Zinzani, Pier Luigi; Okatani, Takeshi; Yoshida, Noriaki; Yoon, Sang Eun; Kim, Won-Seog; Panchoo, Girisha; Mohamed, Zainab; Verburgh, Estelle; Alturas, Jackielyn Cuenca; Al-Mansour, Mubarak; Ford, Josie; Cabrera, Maria Elena; Ku, Amy; Bhagat, Govind; Ma, Helen; Sawas, Ahmed; Kariya, Khyati Maulik; Iwasaki, Makoto; Bhanushali, Forum; O'Connor, Owen A.; Marchi, Enrica; Shen, Changyu; Shah, Devavrat; Jain, Salvia
The combination of hypomethylating agents and histone deacetylase inhibitors produce marked synergy in preclinical models of T-cell lymphoma
2015 Marchi, Enrica; Zullo, Kelly M; Amengual, Jennifer E; Kalac, Matko; Bongero, Danielle; Mcintosh, Christine M; Fogli, Laura K; Rossi, Maura; Zinzani, Pier L; Pileri, Stefano A; Piccaluga, Pier P; Fuligni, Fabio; Scotto, Luigi; O'Connor, Owen A
Pralatrexate is synergistic with the proteasome inhibitor bortezomib in in vitro and in vivo models of T-cell lymphoid malignancies.
2010 Marchi E; Paoluzzi L; Scotto L; Seshan VE; Zain JM; Zinzani PL; O'Connor OA.
Histological verification of positive positron emission tomography findings in the follow-up of patients with mediastinal lymphoma.
2007 Zinzani PL; Tani M; Trisolini R; Fanti S; Stefoni V; Alifano M; Castellucci P; Musuraca G; Dalpiaz G; Alinari L; Marchi E; Fina M; Pellegrini C; Farsad M; Cancellieri A; Busca A; Canini R; Pileri S; Baccarani M; Boaron M.
Early positron emission tomography (PET) restaging: a predictive final response in Hodgkin's disease patients.
2006 Zinzani PL.; Tani M.; Fanti S.; Alinari L.; Musuraca G.; Marchi E.; Stefoni V.; Castellucci P.; Fina M.; Farshad M.; Pileri S.; Baccarani M.
Identification of outcome predictors in diffuse large B-cell lymphoma. Immunohistochemical profiling of homogeneously treated de novo tumors with nodal presentation on tissue micro-arrays.
2005 ZINZANI P.; DIRNHOFER S; SABATTINI E; ALINARI L; PICCALUGA PP; STEFONI V; TANI M; MUSURACA G; MARCHI E; FALINI B; BACCARANI M; PILERI SA.
Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma.
2004 ZINZANI P.; STEFONI V; MUSURACA G; TANI M; ALINARI L; GABRIELE A; MARCHI E; PILERI S; BACCARANI M.
High-dose therapy with autologous transplantation for aggressive non-Hodgkin's lymphoma: the Bologna experience
2004 ZINZANI P.L.; TANI M.; GABRIELE A.; GHERLINZONI F.; DE VIVO A.; RICCI P.; BANDINI G.; LEMOLI R.M.; MOTTA M.R.; RIZZI S.; GUIDICE V.; ZOMPATORI M.; STEFONI V.; ALINARI L.; MUSURACA G.; MARCHI E.; BASSI S.; CONTE R.; PILERI S.; TURA S.; BACCARANI M.
Long-term follow-up of front-line treatment of hairy cell leukemia with 2-chlorodeoxyadenosine
2004 ZINZANI PL; TANI M; MARCHI E; STEFONI V; ALINARI L; MUSURACA G; GABRIELE A; PILERI S; BACCARANI M.
Predictive role of positron emission tomography (PET) in the outcome of lymphoma patients.
2004 Zinzani, PIER LUIGI; Fanti, Stefano; Battista, Giuseppe; Tani, Monica; Castellucci, Paolo; Stefoni, Vittorio; Alinari, Lapo; Farsad, M; Musuraca, G; Gabriele, A; Marchi, Enrica; Nanni, C; Canini, Romeo; Monetti, Nino; Baccarani, Michele